CION Ameerpet
Ovarian cancer is rare before 40 and rarer still in a teenager — and the great majority of ovarian lumps found in young women are not cancer. But the tumours that do occur at this age are not the ones that occur at 60, they show up differently, and they are easy to file away as period pain. This page is about what actually changes when the patient is young.
Uncommon — genuinely uncommon. Ovarian cancer risk climbs steeply with age, and the disease is concentrated in the years after menopause. Cases in the 20s and 30s are a small minority of the total, and ovarian cancer in a teenager is rarer again. If you have typed ovarian cancer young women into a search box after a scan report or a bad night, the statistical answer is on your side.
The second reassurance is bigger than the first. Most ovarian masses found in young women are not cancer at all. Functional cysts that come with ovulation, mature cystic teratomas — dermoids — and endometriomas make up the bulk of what a pelvic ultrasound picks up before 40, and a large share of those need nothing more than a repeat scan.
But “you are too young for that” is not a diagnosis, and it is the sentence that costs young women months. Ovarian tumours do occur at this age. They are simply different tumours — different cells of origin, different markers, different behaviour and a different plan — and the assessment that finds them is not the assessment used in a 62-year-old. That is the point of this page: not to raise your suspicion, but to make sure a real answer gets found quickly. The wider picture is in our complete guide to ovarian cancer.
Ovarian cancer incidence rises with age and peaks well after menopause. Being in your 20s or 30s puts you at the low end of an already uncommon disease.
Most ovarian masses in young women are functional cysts, dermoids or endometriomas. Many resolve on their own; most of the rest are benign and removable.
Germ cell, sex cord-stromal and borderline tumours occur mainly at this age. They are treatable, and often very treatable, when someone looks properly.
Ovarian cancer is overwhelmingly a disease of the years after menopause — but the tumour types invert at the young end of the age range. After 50, the great majority of ovarian malignancies are epithelial, and most of those are high-grade serous. In the first two decades of life the position reverses: malignant germ cell tumours, which arise from the egg-forming cells rather than the ovarian surface, make up the majority of ovarian cancers, alongside sex cord-stromal and borderline tumours. This is why standard management for early-stage disease in a young woman is fertility-sparing surgery — removing the affected ovary and tube while leaving the uterus and the opposite ovary in place. The disease is different, so the operation is different. Source: WHO Classification of Tumours, Female Genital Tumours (5th ed., 2020); NCCN Guidelines, Ovarian Cancer.
Roughly in order of how often each is the answer. The first four are benign and account for most of what is found; the last four are the tumours that make this age group different from the one the textbooks describe.
By far the commonest finding. Every month a follicle grows, releases an egg and collapses into a corpus luteum. Either structure can persist and fill with fluid, producing a simple, thin-walled, fluid-only cyst on ultrasound. They are a sign that the ovary is working, not that it is diseased.
The great majority shrink and disappear within one or two cycles. The standard response to a simple cyst in a young woman is a repeat scan in six to twelve weeks, not surgery. Removing them achieves nothing except the loss of healthy ovarian tissue, which matters later if you want children.
The commonest true ovarian tumour in young women, and it is benign. A dermoid arises from a germ cell that has begun differentiating into ordinary body tissue, so it can contain fat, hair, skin and occasionally teeth. That mixed content gives it a characteristic appearance on ultrasound which a radiologist usually recognises at once.
Dermoids do not resolve on their own and they can grow, which is why larger ones are usually removed — ideally by shelling the tumour out and preserving the rest of the ovary. Malignant change is rare and occurs mainly in older women. The reason to act is size and the risk of the ovary twisting, not a fear of cancer.
Endometriosis affects a substantial minority of women of reproductive age, and when it forms a cyst in the ovary it produces the thick, dark, altered blood that gives it the name chocolate cyst. It has a distinctive ground-glass look on ultrasound, and it usually travels with painful periods, pain with sex or difficulty conceiving.
Endometriomas are benign. Two things are worth saying plainly: they raise CA-125, which is one reason that test misleads so often in young women; and long-standing endometriosis carries a small increase in the risk of clear cell and endometrioid ovarian cancers later in life. A small increase on a small baseline is still a small number — but it is a reason for a proper review rather than years of painkillers.
Serous and mucinous cystadenomas are benign growths of the ovarian surface lining. They can become large — mucinous ones especially — and cause a visible swelling or pressure on the bladder and bowel, which is often what brings a young woman in.
They do not go away on their own and are usually removed, with the ovary preserved wherever the surgeon can. The pathology report after removal is what settles the diagnosis definitively, because a large mucinous tumour cannot always be told from a borderline one on imaging alone.
Borderline tumours, also called tumours of low malignant potential, have abnormal-looking cells but do not invade the ovarian tissue the way a cancer does. They occur disproportionately in younger women, they are usually confined to one ovary when found, and the outlook after complete removal is generally very good.
They are managed with fertility-sparing surgery in almost all young women who want children, and coordinated with a specialist gynaecologic-oncology team, because the operation should be done by someone who will stage it properly if the pathology turns out to be worse than expected. Long-term follow-up matters, as they can come back years later — usually as another borderline tumour rather than as cancer.
Malignant germ cell tumours arise from the egg-forming cells and occur mainly in the teens and twenties. They tend to grow quickly, which sounds alarming but has a practical upside: they usually announce themselves early, often as pain or a palpable mass rather than as months of vague symptoms, and most are confined to one ovary when found.
They are also among the most chemosensitive of all solid cancers, and treatment is planned around a young woman's whole life — fertility-sparing surgery even where the disease has spread, followed where needed by platinum-based combination chemotherapy. The detail is in our guide to germ cell ovarian tumours.
These arise from the cells that normally make the ovary's hormones, so they often declare themselves through hormones rather than through pain. A granulosa cell tumour can produce oestrogen, causing heavy or irregular bleeding, or bleeding and breast development well before the normal age in a child. A Sertoli-Leydig tumour can produce androgens, causing acne, unwanted hair growth, periods stopping or the voice deepening.
Most are found at an early stage and are removed with fertility-sparing surgery. Inhibin B and anti-Mullerian hormone are the useful markers here, which is another reason CA-125 alone is the wrong test in a young woman. Because these tumours can recur late, follow-up runs for years rather than months.
The high-grade serous cancer that dominates ovarian cancer statistics is unusual under 40. When epithelial cancer does occur young, it is more often endometrioid or clear cell — the two subtypes linked to endometriosis — or a mucinous tumour, and it is more often confined to the ovary at diagnosis.
An inherited BRCA1 or BRCA2 variant is the one factor that meaningfully shifts this. BRCA-related ovarian risk begins to rise from the mid-thirties onwards, which is exactly why risk-reducing surgery is discussed around that age rather than left indefinitely. If ovarian, breast, bowel or endometrial cancer runs in your family, genetic counselling is the conversation to have — and CION provides it in-house.
These are generalisations rather than rules — but they are the generalisations that decide which tests get sent and which operation gets planned, so they are worth knowing before your appointment.
| What differs | Typically under 40 | Typically after menopause |
|---|---|---|
| Commonest tumour type | Germ cell, sex cord-stromal and borderline tumours account for a large share. | Epithelial cancer, and most of that high-grade serous. |
| How it shows up | Sudden one-sided pain from the ovary twisting or a cyst rupturing, a lump that can be felt, or hormonal changes. | Weeks to months of bloating, feeling full quickly, pelvic pain and urinary urgency. |
| Stage when found | More often still confined to one ovary — germ cell and borderline tumours are commonly stage I. | More often already spread across the abdominal lining. |
| Which blood markers help | AFP, beta-hCG, LDH and inhibin B, chosen by suspected type. CA-125 misleads frequently before menopause. | CA-125 read alongside imaging, with HE4 and the ROMA score in selected cases. |
| Usual surgery | Fertility-sparing wherever the disease allows — the affected ovary and tube only. | Full staging or debulking surgery, usually including both ovaries and the uterus. |
| Where fertility sits | Central. It has to be settled before treatment starts, not afterwards. | Rarely the deciding issue; menopause has usually already happened. |
*All ovarian surgery, including fertility-sparing surgery and staging, is coordinated with specialist gynaecologic-oncology partner centres and may be billed there. Chemotherapy, genetic counselling and follow-up are delivered in-house at CION.
None of these means cancer. Each is a reason to be examined and scanned rather than to wait another cycle — and the first one is an emergency whatever the cause turns out to be.
Pain that comes on abruptly, often with nausea or vomiting, can mean the ovary has twisted on its blood supply. That is a same-day emergency: the ovary can often be saved if it is untwisted quickly.
Firmness or a swelling low in the abdomen that you can feel, or a waistband that has genuinely changed, warrants an examination and an ultrasound rather than reassurance over the phone.
New bloating, pelvic pain or feeling full quickly, present on most days for more than two or three weeks and not tracking your cycle, is the pattern that earns a scan at any age.
Periods stopping or turning heavy and irregular, new acne, unwanted hair growth or a deepening voice can point to a hormone-producing ovarian tumour. In a child, any bleeding before puberty needs assessment now.
A simple cyst that has not shrunk on the repeat scan, or one reported as complex, solid, or with blood flow inside it, needs specialist review before anyone books an operation.
Ovarian, breast, bowel or endometrial cancer in close relatives, or a known BRCA variant in the family, lowers the threshold for investigating and is a reason for genetic counselling in its own right.
If any of these apply, ask for an appointment rather than waiting for the next symptom. In most young women the assessment ends in reassurance — and when it does not, the options that protect fertility are widest at the start. You can request a free consultation here.
A 45-minute consultation, the right markers for your age, and a plain answer about whether this needs surgery at all. Most young women leave reassured. The few who need more are picked up while the options that protect fertility are still open.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. If the mass is benign — which it usually is at this age — we will tell you plainly and send you home.
The sequence is deliberately different from the one used after menopause. Most young women reach a clear answer within the first three steps, and a good proportion need no operation at all.
How the pain behaves, whether it tracks your cycle, how your periods have changed, whether acne or hair growth is new, and who in the family has had ovarian, breast, bowel or endometrial cancer. A pregnancy test is done early, because pregnancy explains some ovarian findings outright and it raises beta-hCG, which would otherwise be read as a tumour marker.
An abdominal examination looks for a palpable mass, tenderness and free fluid. A pelvic examination is done where it is appropriate for the patient's age and history — in an adolescent or a young woman who is not sexually active it is usually omitted, and the ultrasound does that work instead.
The decisive test. In a teenager or someone not sexually active it is done transabdominally with a full bladder; otherwise a transvaginal scan gives the clearest view. It is painless and radiation-free, and it describes size, whether the mass is simple or complex, solid areas, blood flow and free fluid — the features that decide everything after it.
AFP, beta-hCG and LDH where a germ cell tumour is possible; inhibin B and anti-Mullerian hormone where a stromal tumour is. CA-125 is included selectively and read with real caution, because in young women it rises with endometriosis, fibroids, pelvic infection, pregnancy and even a normal period. Sending CA-125 alone in a 24-year-old creates far more anxiety than information.
If the cyst is simple, fluid-only and thin-walled, the correct next step is usually a repeat scan after six to twelve weeks rather than surgery. Most will have shrunk or gone. This step is skipped far too often, and every avoidable operation on a young ovary costs some ovarian reserve.
Where the ultrasound is indeterminate, an MRI of the pelvis characterises the mass better than CT can. If the picture raises a genuine question of malignancy, the case belongs on a gynaecologic-oncology pathway before an operation is booked — a fertility-sparing procedure that is also staged properly has to be planned that way from the start. At CION the case goes to a tumour board, and surgery is coordinated with specialist gynaecologic-oncology surgeons at partner centres. See how ovarian cancer treatment is organised in Hyderabad.
*There is no screening test for ovarian cancer at any age — not CA-125, not ultrasound, and not for young women with a family history. Screening has been tested in large trials and has not been shown to save lives. Symptoms and risk assessment, not surveillance, are what find this disease.
For most young women the second question arrives about ten seconds after the first: will I still be able to have children? Raise it out loud, at the first consultation, before any operation is booked. Fertility-sparing surgery — taking the affected ovary and tube and leaving the uterus and the other ovary — is the standard approach for early-stage germ cell, sex cord-stromal and borderline tumours, and for selected stage I epithelial cancers. It is a decision made before the operation, not one that can be recovered afterwards. Our guide to ovarian cancer and fertility works through the options in detail.
Chemotherapy is the other half of the conversation. Platinum-based combination chemotherapy can reduce ovarian reserve, and while being young is genuinely protective — periods return in most young women afterwards — that is a group observation and not a promise about you. Where there is time, egg or embryo freezing before treatment is arranged with a fertility unit; where the tumour is growing quickly there may not be time, and that trade-off should be explained to you rather than settled quietly on your behalf.
Then there are the survival figures you have already searched for. Be careful with them. Published ovarian cancer statistics are dominated by high-grade serous cancer diagnosed after 50, often at an advanced stage — a different disease from a stage I germ cell tumour in a 22-year-old, treated differently and with a very different outlook. An average taken across every substage, subtype and age is close to meaningless for one young woman. CION publishes its own one-year figure beside the national one so the comparison is visible rather than implied: 81.0% of CION ovarian cancer patients are alive at one year, against a national figure of 73.7%. Those are one-year figures across everyone treated — not cure rates, and not a prediction for you.
Whether you want children changes which operation is planned. Say it at the first consultation — it cannot be added back once an ovary has been removed.
CION ovarian cancer patients alive at one year from diagnosis. *One-year survival, CION treated population.
The comparable national figure for ovarian cancer. *One-year survival; national registry data.
Published figures average across subtypes, stages and ages, and are weighted towards epithelial cancer after 50. Your subtype and stage matter far more.
*One-year survival rates. CION figures reflect CION's treated patient population; national figures are drawn from published Indian cancer registry data. Survival statistics describe groups, not individuals — discuss your own prognosis with your treating oncologist.
The two failure modes at this age pull in opposite directions. One is being told you are too young for anything to be wrong, and coming back a year later. The other is an unnecessary operation on a benign cyst that would have disappeared on its own, done in a hurry, costing ovarian tissue a young woman will want later. Both come from the same place: a decision made in five minutes without the history.
Your first consultation at CION is free and runs to about 45 minutes. Markers are chosen for your age rather than sent as a panel, a simple-looking cyst gets a repeat scan rather than a theatre date, and any case that raises a real question goes to a tumour board instead of resting on one clinician's opinion. If the answer is that nothing is wrong, we say so plainly.
Be clear about what sits where. CION delivers medical oncology in-house — chemotherapy and maintenance treatment across 35+ centres in Telangana and Andhra Pradesh — along with genetic counselling, BRCA and HRD testing, nutrition support and long-term follow-up. All ovarian surgery, including fertility-sparing surgery and staging, is coordinated with specialist gynaecologic-oncology surgeons at partner centres and may be billed there, and egg or embryo freezing is arranged with a fertility unit. We would rather say that upfront than have you discover it at the billing counter.
Free, unhurried and with a specialist. Long enough to take the history that decides which tests you actually need.
Cases that raise a question are reviewed by medical oncology, imaging and pathology together, not decided by one doctor alone.
Decisions for healing, not billing. A simple cyst in a young woman gets a repeat scan, not a theatre slot.
Chemotherapy cycles and follow-up can be delivered near where you live across Telangana and Andhra Pradesh, rather than repeated trips into the city.
*Fertility-sparing surgery, staging surgery and egg or embryo freezing are coordinated with specialist partner centres and fertility units and may be billed there. Chemotherapy, maintenance therapy, genetic counselling and follow-up are delivered in-house at CION.
Yes, but it is rare. Ovarian cancer in a teenager is uncommon enough that most gynaecologists see only a handful in a career. When it does happen the tumour is usually a malignant germ cell tumour rather than the epithelial cancer that affects older women, and sometimes a sex cord-stromal tumour that announces itself through hormonal changes such as bleeding before puberty or periods stopping. These tumours tend to grow quickly and so tend to be found while still confined to one ovary, and they respond very well to treatment. Far more often, an ovarian mass in a teenager turns out to be a functional cyst or a dermoid, both benign. The symptom that should never be ignored at this age is sudden severe one-sided pain, which can mean the ovary has twisted and needs same-day assessment.
Unlikely. Ovarian cancer risk rises steeply with age, and cases in the 20s make up a small fraction of the total. If you are in your 20s with pelvic pain, bloating or a cyst on a scan, the odds are heavily in favour of a benign explanation: a functional cyst from ovulation, a dermoid, an endometrioma, or a gut cause such as irritable bowel syndrome. That said, the tumours that do occur in this decade are mostly germ cell, sex cord-stromal and borderline tumours, and they are found by taking symptoms seriously rather than by screening, which does not work at any age. A pelvic ultrasound and the right blood markers for your age usually settle the question within a week or two.
They are often less subtle than in older women. Sudden severe pain on one side, from the ovary twisting or a cyst rupturing, is a common way an ovarian tumour first declares itself at this age, and it needs same-day assessment. A lump you can feel low in the abdomen is another. Hormonal changes that do not fit — periods stopping or turning heavy and irregular, new acne, unwanted hair growth, a deepening voice, or in a child any bleeding before puberty — can point to a hormone-producing ovarian tumour. The slower pattern also occurs: bloating, pelvic pain or feeling full quickly on most days for more than two or three weeks, not tracking your cycle. Any of these deserves an examination and a scan.
Almost certainly not. Cysts are extremely common in women who ovulate, and the great majority are functional — a follicle or corpus luteum that filled with fluid and will shrink over one or two cycles. On the scan report the words that reassure are simple, unilocular, anechoic and thin-walled. The correct next step for a cyst like that is usually a repeat scan in six to twelve weeks, not an operation. The findings that warrant specialist review instead are solid areas, internal blood flow, thick or irregular walls, a cyst that has grown rather than shrunk, or free fluid in the abdomen. If your cyst is causing pain, that is worth treating on its own terms, but pain alone does not make a cyst sinister.
Often, yes — but it depends on decisions made before treatment starts, which is why it has to be raised at the first consultation. For early-stage germ cell, sex cord-stromal and borderline tumours, and for selected stage I epithelial cancers, fertility-sparing surgery is the standard approach: the affected ovary and tube are removed and the uterus and the other ovary are left in place. Where chemotherapy is needed, being young is genuinely protective and periods return in most young women, though that is a group pattern rather than a guarantee for any individual. Where there is time before treatment, egg or embryo freezing can be arranged with a fertility unit. All of this is coordinated with specialist partner centres, and none of it can be added back after an operation has already been done.
No — and this is worth saying plainly, because it is often assumed otherwise. There is no effective screening test for ovarian cancer at any age. Large trials of CA-125 and ultrasound surveillance have not shown that screening saves lives, and that conclusion holds even for women who carry a BRCA variant. Regular scans can create false alarms and lead to operations that remove healthy ovaries. What does help if cancer runs in your family is genetic counselling and testing, delivered in-house at CION: knowing whether you carry a BRCA1, BRCA2 or Lynch-related variant changes the conversation about risk-reducing surgery later, usually from the mid-thirties onwards, and it changes what your sisters and daughters need to know.
The first consultation is free and runs to about 45 minutes. CION delivers medical oncology in-house, which covers chemotherapy and maintenance treatment across more than 35 centres in Telangana and Andhra Pradesh, along with genetic counselling, BRCA and HRD testing, nutrition support and long-term follow-up. All ovarian surgery, including fertility-sparing surgery and surgical staging, is coordinated with specialist gynaecologic-oncology surgeons at partner centres and may be billed there, and egg or embryo freezing is arranged with a fertility unit — we say that upfront rather than leaving it to be discovered later. Every case that raises a question is reviewed at a tumour board, and for a young woman the fertility question is put on the table there, before the treatment plan is fixed.